Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis.
about
Pyrroloquinoline quinine inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos in mouse bone marrow cells and inhibits wear particle-induced osteolysis in miceRemodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activationRole of polyethylene particles in peri-prosthetic osteolysis: A review.Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening.Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model.Progranulin suppresses titanium particle induced inflammatory osteolysis by targeting TNFα signaling.Opposing actions of hippocampus TNFα receptors on limbic seizure susceptibility.The central role of wear debris in periprosthetic osteolysis.PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysisElevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study.Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions.Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.Co-Cr-Mo alloy particles induce tumor necrosis factor alpha production in MLO-Y4 osteocytes: a role for osteocytes in particle-induced inflammation.Stimulation of macrophage TNFalpha production by orthopaedic wear particles requires activation of the ERK1/2/Egr-1 and NF-kappaB pathways but is independent of p38 and JNK.What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?
P2860
Q28486296-AA0E1E82-C6CE-449D-9E46-51E48BD182CBQ34345061-87491013-8483-42D4-A1FB-8B7FD11D167BQ34999751-AC40D5F2-1F67-4A12-9129-85F03B65EE1FQ35825373-C023D118-BC97-4E7A-8924-D225ECFBEAE0Q35908576-9E8BBBD6-4E25-46C5-AAB4-B7AA5E5E9FB2Q36127944-72B02861-5F8E-41F8-9DCD-FAC73CF909FEQ36569740-6AD0CF8C-62E6-4FA2-A16B-2A2DE9E6BF27Q36794661-0E0CE3B3-94DF-4E18-A5BA-DFAF22E2CCABQ36796472-1ED5F9DA-2453-4DE6-91DD-BE3C904A3363Q37345108-C0A4B753-4913-44E6-B1FC-9BF2809F35FFQ37472450-CB9B4E92-2BD8-4579-91BC-7E780554CECEQ38044786-1A6CBBFF-E40B-458C-93D5-31A570541A0BQ38148877-07160A31-89DF-4C1E-B45C-205C9ECF4668Q39842640-5CF2B516-4A81-419A-9441-DF1149022F01Q39957832-C09CCA38-9361-4E98-BAC8-97333B410C43Q42562661-7D2C8BEE-9766-4F13-999E-83037104F024
P2860
Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Effect of anti-tumor necrosis ...... ear debris-induced osteolysis.
@en
Effect of anti-tumor necrosis ...... ear debris-induced osteolysis.
@nl
type
label
Effect of anti-tumor necrosis ...... ear debris-induced osteolysis.
@en
Effect of anti-tumor necrosis ...... ear debris-induced osteolysis.
@nl
prefLabel
Effect of anti-tumor necrosis ...... ear debris-induced osteolysis.
@en
Effect of anti-tumor necrosis ...... ear debris-induced osteolysis.
@nl
P2093
P1476
Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis
@en
P2093
E M Schwarz
J J Goater
L M Childs
R J O'Keefe
P304
P356
10.2106/00004623-200112000-00004
P407
P577
2001-12-01T00:00:00Z